| |
| Magyar Sebész Társaság |
|
| 10th EFR (European Federation for coloRectal Cancer Congress) April - 20-22, 2017 Vienna |
 Rendezvény kezdete: 2017.04.20. | Rendezvény vége: 2017.04.22. |
| Szakterület(ek): Sebészet |
| Helyszín: Austria, Vienna, |
| A rendezvény Web oldala: http://www.efrcancer.org/ |
It is a great pleasure and honour to invite you to the 10th EFR – European Federation for coloRectal Cancer Congress to be held from April 20 - 22, 2017 at the Medical University of Vienna. This congress will address state-of-the-art multidisciplinary management of colorectal cancer. The optimal method to diagnose and treat this common cancer requires a multimodality approach: perspectives from endoscopy, pathology, surgery, medical oncology, radiation medicine and biomarker assessment. The symposium sessions will be including life surgeries, hands-on workshop, scientific paper and video presentations.
Apart from a famous Viennese environment during the most beautiful time of the year and a touch of Austrian hospitality, this biannual EFR Conference will prove to be a wonderful opportunity for Colorectal Surgeons from all over the world to get together, learn from each other, and exchange knowledge and experience.
Highlights
• Minimal access colorectal surgery including robotics and laparoscopy
• NOTES and trans-anal access surgery
• Novel Findings in Molecular Biology
• New Horizons in Recent Studies
• Latest Developments in Molecular Imaging
• Translational Medicine approaches in Drug Development
We look forward to welcoming you to an inspiring congress in Vienna 2017.
Website: http://www.efrcancer.org/ >>
Yours sincerely,
Béla Teleky
MD, FRCS
President of the EFR
|
|
|
 |
| |
| Magyar Immunológiai Társaság |
|
| 8th Translational Immunology School |
| Rendezvény kezdete: 2019.04.11. | Rendezvény vége: 2019.04.13. |
| Helyszín: Germany, Potsdam, |
| A rendezvény Web oldala: https://dgfi.org/akademie-fuer-immunologie/translational-school/ |
The School
The Translational Immunology Schools (TIS) up to now were great success stories. They were attended each by more than 50 people from academic research as well as from clinical research institutions and industry. The topics covered include developments in diagnostics, new research technologies, modern immune intervention and new immune therapeutic principles. Moreover there was a focus on vaccines and B cells as important therapeutic targets. Furthermore, we discussed the current status on stem cell therapy, gene therapy and immune therapy of tumors as well as transplantation tolerance in the last translational schools. Similar topics will be presented on our 8th Translational Immunology School. Since 2014 various changes were introduced for the school:
|
|
|
|
